GlassScriptPhysician profile
Jason Costa
NPI 1588007645
$1,599.91
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $280 · 2020: $52.94 · 2021: $383 · 2022: $642 · 2023: $114 · 2024: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $241.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $292.53 | 2022-2024 | |
| Abbott Laboratories | $280.06 | 2019 | |
| Cardiovascular Systems INC. | $208.36 | 2020-2022 | |
| Boston Scientific Corporation | $145.17 | 2022 | |
| Merck Sharp & Dohme LLC | $125.07 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $119.45 | 2020-2022 | |
| Medtronic, INC. | $102.91 | 2023-2024 | Corevalve Evolut R, Axium Primetm |
| Pfizer INC. | $90.06 | 2021-2022 | |
| Cardiva Medical, INC. | $49.55 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Irhythm Technologies, INC. | $30.62 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $29.85 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $27.15 | 2021-2022 | |
| Becton, Dickinson and Company | $21.07 | 2024 | |
| Alnylam Pharmaceuticals INC. | $20.71 | 2022 | |
| Altathera Pharmaceuticals LLC | $16.42 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $14.79 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $14.48 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $11.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Costa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.